Flora Growth Corp. Files 8-K: Material Agreement & Equity Sales
Ticker: ZSTK · Form: 8-K · Filed: Jun 5, 2024 · CIK: 1790169
| Field | Detail |
|---|---|
| Company | Flora Growth Corp. (ZSTK) |
| Form Type | 8-K |
| Filed Date | Jun 5, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.7 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, financials
TL;DR
Flora Growth Corp. filed an 8-K for a material agreement and equity sales. Details to follow.
AI Summary
Flora Growth Corp. announced on June 4, 2024, that it entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and filed financial statements and exhibits. The exact nature of the agreement and the details of the equity sales are not specified in this filing.
Why It Matters
This filing indicates significant corporate activity, including a new material agreement and equity transactions, which could impact the company's financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing mentions a material definitive agreement and unregistered sales of equity securities, which can introduce financial and operational risks if not managed properly.
Key Numbers
- 001-40397 — SEC File Number (Identifies the company's filing with the SEC.)
Key Players & Entities
- Flora Growth Corp. (company) — Registrant
- June 4, 2024 (date) — Date of earliest event reported
- 3230 W. Commercial Boulevard, Suite 180 (address) — Principal executive offices
- Fort Lauderdale, Florida (location) — Principal executive offices location
FAQ
What is the nature of the material definitive agreement entered into by Flora Growth Corp. on June 4, 2024?
The filing does not specify the details of the material definitive agreement.
What type of equity securities were sold by Flora Growth Corp. in the unregistered sales?
The filing mentions unregistered sales of equity securities but does not provide specific details about the type of securities.
What are the key financial statements and exhibits included in this 8-K filing?
The filing indicates that financial statements and exhibits are included, but their specific content is not detailed in the provided text.
Where are Flora Growth Corp.'s principal executive offices located?
Flora Growth Corp.'s principal executive offices are located at 3230 W. Commercial Boulevard, Suite 180, Fort Lauderdale, Florida, 33309.
What is the SEC file number for Flora Growth Corp.?
The SEC file number for Flora Growth Corp. is 001-40397.
Filing Stats: 777 words · 3 min read · ~3 pages · Grade level 11.5 · Accepted 2024-06-05 09:22:16
Key Financial Figures
- $0.7 million — Flora (the " Flora Shares "), valued at $0.7 million based on the closing price of Flora's c
Filing Documents
- form8k.htm (8-K) — 17KB
- exhibit1-1.htm (EX-1.1) — 117KB
- 0001062993-24-011937.txt ( ) — 378KB
- flgc-20240604.xsd (EX-101.SCH) — 5KB
- flgc-20240604_cal.xml (EX-101.CAL) — 1KB
- flgc-20240604_def.xml (EX-101.DEF) — 22KB
- flgc-20240604_lab.xml (EX-101.LAB) — 46KB
- flgc-20240604_pre.xml (EX-101.PRE) — 25KB
- form8k_htm.xml (XML) — 3KB
01 Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement. On June 4, 2024, Flora Growth Corp., a corporation under the laws of the Province of Ontario (" Flora " or the " Company ") and Lifeist Wellness Inc. ("Lifeist") entered into a Share Purchase Agreement (the " Purchase Agreement ") pursuant to which Flora acquired all of the issued and outstanding common shares (the " AV Common Shares ") of Australian Vaporizers Pty Ltd. (" AV "), an online retailer of vaporizers, hardware, and accessories in Australia (the " Transaction "). Under the terms of the Purchase Agreement, Flora acquired 100% of the issued and outstanding AV Common Shares in exchange for the issuance to Lifeist of an aggregate of 550,000 common shares in the capital of Flora (the " Flora Shares "), valued at $0.7 million based on the closing price of Flora's common shares on June 3, 2024, subject to working capital adjustments. The Agreement contains customary representations, warranties and covenants made by each of the parties. In connection with the simultaneous signing of the Purchase Agreement and closing of the Transaction, Flora issued the Flora Shares to Lifeist, delivered closing documents and certificates customary for a transaction of this type and delivered a release of all claims that Flora may have against Lifesit and/or AV relating to the Share Purchase Agreement dated September 17, 2023 between Flora and Lifeist and the purported termination thereof received by Flora from Lifeist on October 20, 2023. Lifeist delivered the AV Common Shares to Flora, the resignations of certain directors and officers and closing documents and certificates customary for a transaction of this type. The Purchase Agreement is attached to this Current Report on Form 8-K as Exhibit 1.1 and is incorporated herein by reference. The foregoing description of the material terms of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the exhibit attached hereto.
02 Unregistered Sales of Equity Securities
Item 3.02 Unregistered Sales of Equity Securities Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02 with respect to the Flora Shares that were issued to Lifeist in connection with the Transaction. The Flora Shares described herein were issued in reliance upon the exemptions from registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended.
01. Exhibits
Item 9.01. Exhibits. Exhibit Description 1.1 Share and Purchase Agreement, dated June 4, 2024, by and between Flora Growth Corp. and Lifeist Wellness Inc. 104 Cover Page Interative Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. FLORA GROWTH CORP. (Registrant) Dated: June 5, 2024 By: /s/ Clifford Starke Clifford Starke Chief Executive Officer